Dental implants in the medically compromised patient

被引:170
作者
Diz, Pedro [1 ]
Scully, Crispian [2 ]
Sanz, Mariano [3 ]
机构
[1] Univ Santiago de Compostela, Sch Med & Dent, Grp Invest Odontol Medicoquirurg OMEQUI, La Coruna 15782, Spain
[2] UCL, London WC1E 6BT, England
[3] Univ Complutense Madrid, Sch Dent, Grp Invest Etiol & Terapeut Periodontal ETEP, E-28040 Madrid, Spain
关键词
Dental implants; Osseointegration; Systemic diseases; Contraindication; TYPE-2; DIABETES-MELLITUS; ORAL LICHEN-PLANUS; ENDOSSEOUS IMPLANTS; OSTEOGENESIS IMPERFECTA; PROSTHODONTIC TREATMENT; ECTODERMAL DYSPLASIA; GLYCEMIC CONTROL; RETROSPECTIVE EVALUATION; EPIDERMOLYSIS-BULLOSA; SUPPORTED PROSTHESES;
D O I
10.1016/j.jdent.2012.12.008
中图分类号
R78 [口腔科学];
学科分类号
100302 [口腔临床医学];
摘要
Objective: It has been suggested that some local and systemic factors could be contraindications to dental implant treatment. The objective of this paper was to evaluate whether success and survival rates of dental implants are reduced in the medically compromised patient. Data/sources: An extensive literature search was conducted using PubMed/Medline, Scopus, Scirus and Cochrane databases up to November 8, 2012. Conclusions: There are very few absolute medical contraindications to dental implant treatment, although a number of conditions may increase the risk of treatment failure or complications. The degree of systemic disease-control may be far more important that the nature of the disorder itself, and individualized medical control should be established prior to implant therapy, since in many of these patients the quality of life and functional benefits from dental implants may outweigh any risks. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:195 / 206
页数:12
相关论文
共 148 条
[91]
Long-Term Results of Endosteal Implants Following Radical Oral Cancer Surgery with and without Adjuvant Radiation Therapy [J].
Linsen, Sabine S. ;
Martini, Markus ;
Stark, Helmut .
CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, 2012, 14 (02) :250-258
[92]
Lopez-Jimenez Julian, 2003, Med Oral, V8, P288
[93]
What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review [J].
Madrid, Carlos ;
Sanz, Mariano .
CLINICAL ORAL IMPLANTS RESEARCH, 2009, 20 :87-95
[94]
What influence do anticoagulants have on oral implant therapy? A systematic review [J].
Madrid, Carlos ;
Sanz, Mariano .
CLINICAL ORAL IMPLANTS RESEARCH, 2009, 20 :96-106
[95]
Osseointegrated Implant Rehabilitation of Irradiated Oral Cancer Patients [J].
Mancha de la Plata, Maria ;
Naval Gias, Luis ;
Martos Diez, Pedro ;
Munoz-Guerra, Mario ;
Gonzalez-Garcia, Raul ;
Lee, Gui-Youn Cho ;
Castrejon-Castrejon, Sergio ;
Rodriguez-Campo, Francisco J. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2012, 70 (05) :1052-1063
[96]
Dental implants and diabetes: Conditions for success [J].
Marchand, F. ;
Raskin, A. ;
Dionnes-Hornes, A. ;
Barry, T. ;
Dubois, N. ;
Valero, R. ;
Vialettes, B. .
DIABETES & METABOLISM, 2012, 38 (01) :14-19
[97]
Marchini L, 2011, J ORAL IMPLANTOLOGY
[98]
Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris [J].
Maurer, P. ;
Sandulescu, T. ;
Kriwalsky, M. S. ;
Rashad, A. ;
Hollstein, S. ;
Stricker, I. ;
Hoelzle, F. ;
Kunkel, M. .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2011, 40 (03) :285-291
[99]
Meijer G J, 2008, Ned Tijdschr Tandheelkd, V115, P643
[100]
Memon S, 2012, INT J ORAL MAX IMPL, V27, P1216